Synthesis and evaluation of water-soluble poly(vinyl alcohol)-paclitaxel conjugate as a macromolecular prodrug

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 5, 2008, Pages 963-969

  Kakinoki, Atsufumi ^a   Kaneo, Yoshiharu ^a   Tanaka, Tetsuro ^a   Hosokawa, Yoshitsugu ^a  

^a FUKUYAMA UNIVERSITY   (Japan)

Author keywords

Antitumor activity; Cytotoxicity; Macromolecular prodrug; Paclitaxel; Poly(vinyl alcohol)

Indexed keywords

ETHYLENEDIAMINE; PACLITAXEL; POLYVINYL ALCOHOL; SUCCINIC ANHYDRIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CIRCULATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG PENETRATION; DRUG RELEASE; DRUG RETENTION; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; GROWTH INHIBITION; MALE; MOUSE; NONHUMAN; SARCOMA; SARCOMA CELL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOXORUBICIN; DRUG CARRIERS; HYDROGEN-ION CONCENTRATION; INJECTIONS, INTRAVENOUS; KINETICS; LEUKEMIA L1210; MALE; MICE; PACLITAXEL; POLYVINYL ALCOHOL; PRODRUGS; SARCOMA 180; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TISSUE DISTRIBUTION; WATER;

EID: 44349123949     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.963     Document Type: Article

References (39)

1. Wani M. C., Taylor H. L., Wall M. E., Coggon P., McPhail A. T., J. Am. Chem. Soc., 93, 2325-2327 (1971).
2. Arbuck S. G., Christian M. C., Fisherman J. S., Cazenave L. A., Sarosy G., Suffness M., Adams J., Canetta R., Cole K. E., Friedman M. A., J. Natl. Cancer Inst. Monogr., 15, 11-24 (1993).
3. Cahan M. A., Walter K. A., Colvin O. M., Brem H., Cancer Chemother. Pharmacol., 33, 441-444 (1994).
4. Foa R., Norton L., Seidman A. D., Int. J. Clin. Lab. Res., 24, 6-14 (1994).
5. Long H. J., Mayo Clin. Proc., 69, 341-345 (1994).
6. Wiernik P. H., Einzig A. I., J. Natl. Cancer Inst. Monogr., 15, 185-187 (1993).
7. Lee J., Lee S. C., Acharya G., Chang C. J., Park K., Pharm. Res., 20, 1022-1030 (2003).
8. Fjallskog M. L., Frii L., Bergh J., Lancet, 342, 8873-8875 (1993).
9. Panchagnula R., Int. J. Pharm., 172, 1-15 (1998).
10. Einzig A. I., Wiernik P. H., Sasloff J., Runowicz C. D., Goldberg G. L., J. Clin. Oncol., 10, 1748-1753 (1992).
11. Rogers B. B., Oncol. Nurs. Forum, 20, 1483-1489 (1993).
12. Goldspiel B. R., Ann. Pharmacother., 28, S23-S26 (1994).
13. Li C., Yu D., Inoue T., Yang D. J., Milas L., Hunter N. R., Kim E. E., Wallace S., Anticancer Drugs, 7, 642-648 (1996).
14. Greenwald R. B., Gilbert C. W., Pendri A., Conover C. D., Xia J., Martinez A., J. Med. Chem., 39, 424-431 (1996).
15. Li C., Price J. E., Milas L., Hunter N. R., Ke S., Yu D. F., Charnsangavej C., Wallace S., Clin. Cancer Res., 5, 891-897 (1999).
16. Li C., Yu D. F., Newman R. A., Cabral F., Stephens L. C., Hunter N., Milas L., Wallace S., Cancer Res., 58, 2404-2409 (1998).
17. Singer J. W., Baker B., De Vries P., Kumar A., Shaffer S., Vawter E., Bolton M., Garzone P., Adv. Exp. Med. Biol., 519, 81-99 (2003).
18. Sugahara S., Kajiki M., Kuriyama H., Kobayashi T. R., Biol. Pharm. Bull., 25, 632-641 (2002).
19. Ringsdorf H., J. Polym. Sci. Polym. Symp., 51, 135-153 (1975).
20. Seymour L. W., Crit. Rev. Ther. Drug Carrier Syst., 9, 135-187 (1992).
21. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D. A., Torchilin V. P., Jain R. K., Cancer Res., 55, 3752-3756 (1995).
22. Maeda H., Adv. Enzyme Regul., 41, 189-207 (2001).
23. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K., J. Controlled Release, 65, 271-284 (2000).
24. Maeda H., Matsumura Y., Crit. Rev. Ther. Drug Carrier Syst., 6, 193-210 (1989).
25. Mallapragada S. K., McCarthy-Schroeder S., "Handbook of Pharmaceutical Controlled Release Technology," Marcel Dekker, New York, 2000, pp. 31-46.
26. Kakinoki A., Kaneo Y., Ikeda Y., Tanaka T., Fujita K., Biol. Pharm. Bull., 31, 103-110 (2008).
27. Kaneo Y., Hashihama S., Kakinoki A., Tanaka T., Nakano T., Ikeda Y., Drug Metab. Pharmacokinet., 20, 435-442 (2005).
28. Hearn M. T., Methods Enzymol., 135, 102-117 (1987).
29. Beauchamp C. O., Gonias S. L., Menapace D. P., Pizzo S. V., Anal. Biochem., 131, 25-33 (1983).
30. Habeeb A. F., Anal. Biochem., 14, 328-336 (1966).
31. Fields R., Biochem. J., 124, 581-590 (1971).
32. Fields R., Methods Enzymol., 25, 464-468 (1972).
33. Dosio F., Brusa P., Crosasso P., Arpicco S., Cattel L., J. Controlled Release, 47, 293-304 (1997).
34. de Fries R., Mitsuhashi M., J. Clin. Lab. Anal., 9, 89-95 (1995).
35. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
36. Ringel I., Horwitz S. B., J. Pharmacol. Exp. Ther., 242, 692-698 (1987).
37. Baek N., Lee J., Park K., J. Biomater. Sci. Polym. Ed., 15, 527-542 (2004).
38. Konno T., Watanabe J., Ishihara K., J. Biomed. Mater. Res. A, 65, 209-214 (2003).
39. Wada M., Jinno H., Ueda M., Ikeda T., Kitajima M., Konno T., Watanabe J., Ishihara K., Anticancer Res., 27, 1431-1435 (2007).